Related references
Note: Only part of the references are listed.Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms' Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49)
Dorin Novacescu et al.
BIOMEDICINES (2022)
Novel Expression of Thymine Dimers in Renal Cell Carcinoma, Demonstrated through Immunohistochemistry
Dorin Novacescu et al.
BIOMEDICINES (2022)
Safe and pivotal approaches using contrast-enhanced ultrasound for the diagnostic workup of non-obstetric conditions during pregnancy, a single-center experience
Vincent Schwarze et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)
Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Shohei Fukuda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial
Ziho Lee et al.
JOURNAL OF UROLOGY (2020)
Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture
Kvetoslava Michalova et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
The Prognostic Value of Systemic Inflammatory Markers in Advanced Renal Cell Carcinoma Patients Treated With Molecular Targeted Therapies
Kosuke Ueda et al.
ANTICANCER RESEARCH (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma
Giuseppe Stefano Netti et al.
AGING-US (2020)
Gender-Related Approach to Kidney Cancer Management: Moving Forward
Mariangela Mancini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prognostic significance of PI3K/AKT/mTOR signaling pathway members in clear cell renal cell carcinoma
Demin Fan et al.
PEERJ (2020)
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial
Anup Patel et al.
CLINICAL CANCER RESEARCH (2020)
Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling
Yajuan J. Liu et al.
HUMAN PATHOLOGY (2020)
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Alessandra Raimondi et al.
FRONTIERS IN ONCOLOGY (2020)
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
Robert J. Motzer et al.
NATURE MEDICINE (2020)
Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer
Veronica Ghini et al.
CANCERS (2020)
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells
Silvia Bombelli et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment
Roberto Tamma et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma
Keng Lim Ng et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2019)
Eosinophilic Kidney Tumors Old and New
Kenneth A. Iczkowski et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Diagnostic role of kidney injury molecule-1 in renal cell carcinoma
Kevin J. Zhang et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2019)
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
Lynda Vuong et al.
CANCER DISCOVERY (2019)
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge
Anna Calio et al.
CANCERS (2019)
Spontaneous perirenal hemorrhage in hemodialysis patient treated with selective embolization: A case series and review of the literature
Yun Xie et al.
HEMODIALYSIS INTERNATIONAL (2018)
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
Evaluation of renal lesions using contrast-enhanced ultrasound (CEUS); a 10-year retrospective European single-centre analysis
Johannes Ruebenthaler et al.
EUROPEAN RADIOLOGY (2018)
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling
Sumanta K. Pal et al.
EUROPEAN UROLOGY (2018)
Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms
Charles H. Lawrie et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Metabolomics and Metabolic Reprogramming in Kidney Cancer
Robert H. Weiss
SEMINARS IN NEPHROLOGY (2018)
Prognostic factors and prognostic models for renal cell carcinoma: a literature review
Tobias Klatte et al.
WORLD JOURNAL OF UROLOGY (2018)
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J. Ricketts et al.
CELL REPORTS (2018)
Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis
Lijin Zhang et al.
BMC CANCER (2018)
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
AGING-US (2018)
LBA31Molecular correlates differentiate response to atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC)
B I Rini et al.
ANNALS OF ONCOLOGY (2018)
KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study
Ghislaine Scelo et al.
CLINICAL CANCER RESEARCH (2018)
Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologists
Matthew S. Davenport et al.
ABDOMINAL RADIOLOGY (2017)
GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics
Jose G. Mantilla et al.
HUMAN PATHOLOGY (2017)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli et al.
SCIENCE (2017)
Advances in medical imaging for the diagnosis and management of common genitourinary cancers
Mohammad H. Bagheri et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation
Cristina Bianchi et al.
ONCOTARGET (2017)
Incidental detection of renal cell carcinoma
Christian Beisland
SCANDINAVIAN JOURNAL OF UROLOGY (2017)
Renal Medullary Carcinoma: Establishing Standards in Practice
Kathryn E. Beckermann et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis
Rola M. Saleeb et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Jozefina Casuscelli et al.
JCI INSIGHT (2017)
Biphasic Squamoid Alveolar Renal Cell Carcinoma A Distinctive Subtype of Papillary Renal Cell Carcinoma?
Ondrej Hes et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms
Sara M. Falzarano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene
Hironori Kusano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Eosinophilic, Solid, and Cystic Renal Cell Carcinoma Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women
Kiril Trpkov et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review
Ondrej Hes et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2016)
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling
Sumanta K. Pal et al.
EUROPEAN UROLOGY (2016)
Prospective Evaluation of 99mTc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors
Michael A. Gorin et al.
EUROPEAN UROLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma
Susie L. Hu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?
Franziska Erlmeier et al.
MEDICAL ONCOLOGY (2016)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy
Daniel M. Moreira et al.
WORLD JOURNAL OF UROLOGY (2016)
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation
Jianmin Wang et al.
ONCOTARGET (2016)
Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma
Dae Sung Cho et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2016)
Thyroid-Like Follicular Carcinoma of the Kidney One Case Report and Review of the Literature
Rahul Dawane et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
PSF/SFPQ Is a Very Common Gene Fusion Partner in TFE3 Rearrangement-associated Perivascular Epithelioid Cell Tumors (PEComas) and Melanotic Xp11 Translocation Renal Cancers Clinicopathologic, Immunohistochemical, and Molecular Characteristics Suggesting Classification as a Distinct Entity
Qiu Rao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature
Kvetoslava Peckova et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2015)
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Steven P. Rowe et al.
ANNALS OF NUCLEAR MEDICINE (2015)
Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects
Ming Zhao et al.
DIAGNOSTIC PATHOLOGY (2015)
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Borje Ljungberg et al.
EUROPEAN UROLOGY (2015)
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Brian Rini et al.
LANCET ONCOLOGY (2015)
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype
A. Ari Hakimi et al.
MODERN PATHOLOGY (2015)
Short- and long-term effects of chromosome mis-segregation and aneuploidy
Stefano Santaguida et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dube Syndrome
Yasuhiro Iribe et al.
PATHOLOGY INTERNATIONAL (2015)
DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma
Wei Zhao et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
MiT family translocation renal cell carcinoma
Pedram Argani
SEMINARS IN DIAGNOSTIC PATHOLOGY (2015)
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
Giuseppe Lucarelli et al.
ONCOTARGET (2015)
Immunohistochemical Analysis of Cytochrome c Oxidase Facilitates Differentiation Between Oncocytoma and Chromophobe Renal Cell Carcinoma
Alexander C. Adam et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2015)
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
Sean R. Williamson et al.
MODERN PATHOLOGY (2015)
Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology Report From the International Society of Urological Pathology Consensus Conference
Mahul B. Amin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
The Morphologic and Immunohistochemical Spectrum of Papillary Renal Cell Carcinoma Study Including 132 Cases With Pure Type 1 and Type 2 Morphology As Well As Tumors With Overlapping Features
Myriam Chevarie-Davis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Best Practices Recommendations in the Application of Immunohistochemistry in the Kidney Tumors Report From the International Society of Urologic Pathology Consensus Conference
Victor E. Reuter et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
GATA3: A Multispecific But Potentially Useful Marker in Surgical Pathology A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity A Clinicopathologic Series of 36 Tumors From 27 Patients
Anthony J. Gill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
VCL-ALK Renal Cell Carcinoma in Children With Sickle-cell Trait The Eighth Sickle-cell Nephropathy?
Nathaniel E. Smith et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
T. K. Choueiri et al.
ANNALS OF ONCOLOGY (2014)
Loss of BAP1 Protein Expression Is an Independent Marker of Poor Prognosis in Patients With Low-Risk Clear Cell Renal Cell Carcinoma
Richard W. Joseph et al.
CANCER (2014)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis et al.
CANCER CELL (2014)
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms
Nilda Gonzalez-Roibon et al.
HUMAN PATHOLOGY (2014)
BAP1 Immunohistochemistry Predicts Outcomes in a Multi-Institutional Cohort with Clear Cell Renal Cell Carcinoma
Payal Kapur et al.
JOURNAL OF UROLOGY (2014)
Renal Medullary Carcinoma Molecular, Immunohistochemistry, and Morphologic Correlation
Qingyan Liu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
John R. Srigley et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Malignant tumors with clear cell morphology: a comparative immunohistochemical study with renal cell carcinoma antibody, Pax8, steroidogenic factor 1, and brachyury
Erica Fan Clayton et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2013)
Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma
Nils Kroeger et al.
CANCER (2013)
Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
A. Ari Hakimi et al.
CLINICAL CANCER RESEARCH (2013)
Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
EUROPEAN UROLOGY (2013)
Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug
Robin J. Young et al.
FUTURE ONCOLOGY (2013)
Loss of PBRM1 expression is associated with renal cell carcinoma progression
Rafal Pawlowski et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
Payal Kapur et al.
LANCET ONCOLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT
Jonathan R. Young et al.
RADIOLOGY (2013)
Multiphasic Enhancement Patterns of Small Renal Masses (≤4 cm) on Preoperative Computed Tomography: Utility for Distinguishing Subtypes of Renal Cell Carcinoma, Angiomyolipoma, and Oncocytoma
Phillip M. Pierorazio et al.
UROLOGY (2013)
Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas
Nicolas Pote et al.
VIRCHOWS ARCHIV (2013)
Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update
Nelson G. Ordonez
ADVANCES IN ANATOMIC PATHOLOGY (2012)
Multilocular Cystic Renal Cell Carcinoma Similarities and Differences in Immunoprofile Compared With Clear Cell Renal Cell Carcinoma
Sean R. Williamson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Expression of OCT3/4 in Renal Medullary Carcinoma Represents a Potential Diagnostic Pitfall
Priya Rao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Translocation Renal Cell Carcinomas in Adults: A Single-institution Experience
Minghao Zhong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Role of Immunohistochemistry in Diagnosing Renal Neoplasms When Is It Really Useful?
Steven S. Shen et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
S. H. Sim et al.
BRITISH JOURNAL OF CANCER (2012)
N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas
Lucas Moretti et al.
MODERN PATHOLOGY (2012)
RENAL Nephrometry Score Predicts Surgery Type Independent of Individual Surgeon's Use of Nephron-sparing Surgery
Conrad M. Tobert et al.
UROLOGY (2012)
RENAL Nephrometry Score is Associated With Operative Approach for Partial Nephrectomy and Urine Leak
Sean P. Stroup et al.
UROLOGY (2012)
Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients
Xiaozhi Zhao et al.
ABDOMINAL IMAGING (2012)
Differential Diagnosis of Renal Tumors With Papillary Architecture
Satish K. Tickoo et al.
ADVANCES IN ANATOMIC PATHOLOGY (2011)
Incidental Finding of Renal Masses at Unenhanced CT: Prevalence and Analysis of Features for Guiding Management
Stacy D. O'Connor et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Immunohistochemical Distinction of Primary Adrenal Cortical Lesions From Metastatic Clear Cell Renal Cell Carcinoma: A Study of 248 Cases
Ankur R. Sangoi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Renal nephrometry score is associated with urine leak after partial nephrectomy
Bryan Bruner et al.
BJU INTERNATIONAL (2011)
ALK Rearrangement in Sickle Cell Trait-Associated Renal Medullary Carcinoma
Adrian Marino-Enriquez et al.
GENES CHROMOSOMES & CANCER (2011)
Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors
Petra I. Lorenzo et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2011)
Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases
Julien Adam et al.
HISTOPATHOLOGY (2011)
Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes
Zoran Gatalica et al.
HUMAN PATHOLOGY (2011)
VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma
Adriana von Teichman et al.
MODERN PATHOLOGY (2011)
Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins
Stephen M. Rohan et al.
MODERN PATHOLOGY (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Renal Tumors and Hereditary Pheochromocytoma-Paraganglioma Syndrome Type 4
Anthony J. Gill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Use of Immunohistochemistry in the Diagnosis of Metastatic Clear Cell Renal Cell Carcinoma A Review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10
Ankur R. Sangoi et al.
ADVANCES IN ANATOMIC PATHOLOGY (2010)
PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC) A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract
Roula Albadine et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy
Toni K. Choueiri et al.
BJU INTERNATIONAL (2010)
Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma
Alessandro Antonelli et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy
Liang Cheng et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Kidney Tumor Location Measurement Using the C Index Method
Matthew N. Simmons et al.
JOURNAL OF UROLOGY (2010)
Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma
Shams Halat et al.
MODERN PATHOLOGY (2010)
Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases
Fredrik Petersson et al.
VIRCHOWS ARCHIV (2010)
Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee
Lincoln L. Berland et al.
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2010)
The Utility of Pax-2 and Renal Cell Carcinoma Marker Immunohistochemistry in Distinguishing Papillary Renal Cell Carcinoma From Nonrenal Cell Neoplasms With Papillary Features
Shree G. Sharma et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
PAX-2 Expression in Non-neoplastic, Primary Neoplastic, and Metastatic Neoplastic Tissue A Comprehensive Immunohistochemical Study
Qihui Jim Zhai et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
PAX-2 in the Diagnosis of Primary Renal Tumors Immunohistochemical Comparison With Renal Cell Carcinoma Marker Antigen and Kidney-Specific Cadherin
Ayhan Ozcan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical Applicability
Christian Eichelberg et al.
EUROPEAN UROLOGY (2009)
Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery
Vincenzo Ficarra et al.
EUROPEAN UROLOGY (2009)
Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma
Adeboye O. Osunkoya et al.
HUMAN PATHOLOGY (2009)
Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma
Tobias Klatte et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
Marianna Sabatino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The RENAL Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
Alexander Kutikov et al.
JOURNAL OF UROLOGY (2009)
Safety and bio-effects of ultrasound contrast agents
Gail ter Haar
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING (2009)
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma
Anne Gentil Perret et al.
BJU INTERNATIONAL (2008)
Renal cell cancer stage migration - Analysis of the National Cancer Data Base
Christopher J. Kane et al.
CANCER (2008)
Cytologic findings of acquired cystic disease-associated renal cell carcinoma: A report of two cases
Michael Rivera et al.
DIAGNOSTIC CYTOPATHOLOGY (2008)
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma
Brian I. Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer
Guorong Li et al.
JOURNAL OF UROLOGY (2008)
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma
Toni K. Choueiri et al.
JOURNAL OF UROLOGY (2008)
Management of the incidental renal mass
Stuart G. Silverman et al.
RADIOLOGY (2008)
Epidemiology, Clinical Staging, and Presentation of Renal Cell Carcinoma
G. Joel DeCastro et al.
UROLOGIC CLINICS OF NORTH AMERICA (2008)
Hypoxia-inducible factor 1α in clear cell renal cell carcinoma
Tobias Klatte et al.
CLINICAL CANCER RESEARCH (2007)
Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia
Michael S. Wiesener et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma
Bradley C. Leibovich et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors - Diagnostic implications
Nasir Bakshi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Mucinous tubular and spindle cell carcinoma of the kidney: Cytopathologic findings
Christopher L. Owens et al.
DIAGNOSTIC CYTOPATHOLOGY (2007)
Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma
Johanna Sandlund et al.
BJU INTERNATIONAL (2007)
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma
Daniel Cho et al.
CLINICAL GENITOURINARY CANCER (2007)
Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum
Pedram Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Differential diagnosis of Hypercalcemia in renal malignancy
Tobias Klatte et al.
UROLOGY (2007)
Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features
Steven S. Shen et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2007)
Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2 - Value in the differential diagnosis of chromophobe cell carcinoma
Lorenzo Memeo et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
WT1 (Wilms' tumor 1) peptide immunotherapy for renal cell carcinoma
Tatsuo Iiyama et al.
MICROBIOLOGY AND IMMUNOLOGY (2007)
Hypoxia-inducible factor lot expression in renal cell carcinoma analyzed by tissue microarray
Anders Lidgren et al.
EUROPEAN UROLOGY (2006)
Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney
Samson W. Fine et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Cytologic and histologic findings in multiple renal hybrid oncocytic tumors in a patient with Birt-Hogg-Dube syndrome - A case report
Brian P. Adley et al.
ACTA CYTOLOGICA (2006)
The safety of Sonovue® in abdominal applications:: Retrospective analysis of 23188 investigations
Fabio Piscaglia et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2006)
Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma
BP Adley et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Alpha-methyl CoA racemase expression in renal cell carcinomas
V Molinié et al.
HUMAN PATHOLOGY (2006)
Prognostic value of thrombocytosis in renal cell carcinoma
K Bensalah et al.
JOURNAL OF UROLOGY (2006)
Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas
P Brandal et al.
MODERN PATHOLOGY (2006)
Mucinous tubular and spindle cell carcinoma of the kidney with neuroendocrine differentiation - Report of two cases
SJ Jung et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study
Paolo Cossu-Rocca et al.
MODERN PATHOLOGY (2006)
Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney - Significant immunophenotypic overlap warrants diagnostic caution
GP Paner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
An update of the Bosniak renal cyst classification system
GM Israel et al.
UROLOGY (2005)
Stauffer's syndrome variant associated with renal cell carcinoma
G Giannakos et al.
INTERNATIONAL JOURNAL OF UROLOGY (2005)
Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms
SS Shen et al.
MODERN PATHOLOGY (2005)
The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms
M Zhou et al.
CLINICS IN LABORATORY MEDICINE (2005)
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer
M Atkins et al.
CLINICAL CANCER RESEARCH (2005)
Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease - A comprehensive study
N Sule et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas
L Huo et al.
HUMAN PATHOLOGY (2005)
Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma
M Brunelli et al.
MODERN PATHOLOGY (2005)
An immunohistochemical approach to the differential diagnosis of renal tumors
BF Skinnider et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2005)
Cachexia-like symptoms predict a worse prognosis in localized T1 renal cell carcinoma
HL Kim et al.
JOURNAL OF UROLOGY (2004)
Sarcomatoid renal cell carcinoma - An examination of underlying histologic subtype and an analysis of associations with patient outcome
JC Cheville et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases
C Langner et al.
MODERN PATHOLOGY (2004)
Multi-institutional validation of a symptom based classification for renal cell carcinoma
JJ Patard et al.
JOURNAL OF UROLOGY (2004)
CD10 is expressed in a subset of chromophobe renal cell carcinomas
G Martignoni et al.
MODERN PATHOLOGY (2004)
Impact of imaging and thrombus level in management of renal cell carcinoma extending to veins
NP Gupta et al.
UROLOGIA INTERNATIONALIS (2004)
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma
A Lipton et al.
CANCER (2003)
Paraneoplastic signs and symptoms of renal cell carcinoma: Implications for prognosis
HL Kim et al.
JOURNAL OF UROLOGY (2003)
Renal medullary carcinoma: Clinical, pathologic, immunohistochemical, and genetic analysis with pathogenic implications
MA Swartz et al.
UROLOGY (2002)
Contemporary diagnosis and management of renal angiomyolipoma
CP Nelson et al.
JOURNAL OF UROLOGY (2002)
Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma
ME Sanders et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
P Schraml et al.
JOURNAL OF PATHOLOGY (2002)
Getting your Pax straight: Pax proteins in development and disease
N Chi et al.
TRENDS IN GENETICS (2002)
Diagnosing primary and metastatic renal cell carcinoma - The use of the monoclonal antibody 'renal cell carcinoma marker'
DK McGregor et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Parvalbumin is constantly expressed in chromophobe renal carcinoma
G Martignoni et al.
MODERN PATHOLOGY (2001)
Hypertension: A rare presentation of renal cell carcinoma
MR Moein et al.
JOURNAL OF UROLOGY (2000)
Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms - Frequent expression in renal cell carcinoma and endometrial stromal sarcoma
PG Chu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Renal cell carcinoma: Prognostic significance of incidentally detected tumors
KH Tsui et al.
JOURNAL OF UROLOGY (2000)
Share Paper
